These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inappropriate data and measures lead to questionable conclusions--reply. Gibbons RD; Brown CH; Hur K; Davis JM; Mann JJ JAMA Psychiatry; 2013 Jan; 70(1):122-3. PubMed ID: 23303298 [No Abstract] [Full Text] [Related]
4. Inappropriate data and measures lead to questionable conclusions. Spielmans GI; Jureidini J; Healy D; Purssey R JAMA Psychiatry; 2013 Jan; 70(1):121-2. PubMed ID: 23303283 [No Abstract] [Full Text] [Related]
5. Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Gibbons RD; Brown CH; Hur K; Davis J; Mann JJ Arch Gen Psychiatry; 2012 Jun; 69(6):580-7. PubMed ID: 22309973 [TBL] [Abstract][Full Text] [Related]
6. Venlafaxine versus fluoxetine. Paton C J Clin Psychiatry; 1999 Oct; 60(10):708. PubMed ID: 10549691 [No Abstract] [Full Text] [Related]
7. Antidepressant use during pregnancy. FPIN’s clinical inquiries. Patel BN; Beste J; Blackwell JC Am Fam Physician; 2011 May; 83(10):1211-5. PubMed ID: 21568258 [No Abstract] [Full Text] [Related]
9. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)]. Hjalmarsson L; Corcos M; Jeammet P Encephale; 2005; 31(3):309-16. PubMed ID: 16142045 [TBL] [Abstract][Full Text] [Related]
10. Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. Gibbons RD; Hur K; Brown CH; Davis JM; Mann JJ Arch Gen Psychiatry; 2012 Jun; 69(6):572-9. PubMed ID: 22393205 [TBL] [Abstract][Full Text] [Related]
11. A case of high-dose venlafaxine-related psychosis. Dennison EA; Raidoo BM; Cruz R; Raidoo D J Clin Psychopharmacol; 2013 Feb; 33(1):134-6. PubMed ID: 23288238 [No Abstract] [Full Text] [Related]
12. Agomelatine: new drug. Adverse effects and no proven efficacy. Prescrire Int; 2009 Dec; 18(104):241-5. PubMed ID: 20020562 [TBL] [Abstract][Full Text] [Related]
13. Fluoxetine-Induced Severe Oral Ulceration in a 13-Year-Old Girl. Chandradasa M; Champika L J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):469-470. PubMed ID: 28277790 [No Abstract] [Full Text] [Related]
15. Venlafaxine versus SSRI therapy for major depression. Results of comparative efficacy trials. Bakish D Postgrad Med; 1999 Nov; 106(6 Suppl):24-30. PubMed ID: 19667501 [TBL] [Abstract][Full Text] [Related]
16. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms. Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668 [TBL] [Abstract][Full Text] [Related]
17. Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study. Chen Y; Cao X; Zang W; Tan S; Ou CQ; Shen X; Gao T; Zhao L Trials; 2019 Jan; 20(1):34. PubMed ID: 30626424 [TBL] [Abstract][Full Text] [Related]
20. The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step. Brent DA Depress Anxiety; 2009; 26(10):871-4. PubMed ID: 19798756 [No Abstract] [Full Text] [Related] [Next] [New Search]